Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues

Experimental Hematology

Volumn 37, Issue 9, 2009, Pages 1084-1095

  Araki, Hiroto ^a   Baluchamy, Sudhakar ^a   Yoshinaga, Kazumi ^a   Petro, Benjamin ^a   Petiwala, Sakina ^a   Parajuli, Ritesh ^a   Milhem, Mohammed ^a   Lavelle, Donald ^a   DeSimone, Joseph ^a   Mahmud, Nadim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FLT3 LIGAND; L SELECTIN; PROTEIN P21; STEM CELL FACTOR; THROMBOPOIETIN; THY 1 ANTIGEN; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DIVISION; CELL FATE; CELL HOMING; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; CULTURE TECHNIQUE; ENGRAFTMENT; EPIGENETICS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; UMBILICAL CORD BLOOD;

ADULT; ANIMALS; ANTIGENS, CD34; ANTIGENS, THY-1; AZACITIDINE; CELL CULTURE TECHNIQUES; CELL DIVISION; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINES; ENZYME INHIBITORS; EPIGENESIS, GENETIC; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROXAMIC ACIDS; MICE; MICE, INBRED NOD; MICE, SCID; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 68549083646     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.05.012     Document Type: Article

References (32)

1. Blau H.M. Differentiation requires continuous active control. Annu Dev Biochem 61 (1992) 1213-1230
2. Jones P.A., and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293 (2001) 1068-1070
3. Marks P.A., Richon V.M., and Rifkind R.A. Histone deacetylases inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92 (2000) 1210-1216
4. Kass S.U., Pruss D., and Wolffe A.P. How dose methylation mediated repress transcription?. Trends Genet 13 (1997) 444-449
5. Issa J.P. Decitabine. Curr Opin Oncol 15 (2003) 446-451
6. Mahmud N., Milhem M., Araki H., and Hoffman R. Alteration of hematopoietic stem cell fates by chromatin-modifying agents. In: Ho A.D., Hoffman R., and Zanjani E.D. (Eds). Frontiers in Stem Cell Transplantation (2006), Wiley-VCH, Weinheim, Germany 27-42
7. Ueda T., Tsuji K., Yoshino H., et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 105 (2000) 1013-1021
8. + cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 93 (1999) 3736-3749
9. Habibian H.K., Peters S.O., Hsieh C.C., et al. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med 188 (1998) 393-398
10. Takatoku M., Sellers S., Agricola B.A., et al. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 108 (2001) 447-455
11. Glimm H., Oh I.H., and Eaves C.J. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 96 (2000) 4185-4193
12. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Gene 33 (2003) 245-254
13. Araki H., Yoshinaga K., Boccuni P., Zhao Y., Hoffman R., and Mahmud N. Chromatin modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 109 (2007) 3570-3578
14. Araki H., Mahmud N., Milhem M., et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin modifying agents. Exp Hematol 34 (2006) 140-149
15. Xu M., Bruno E., Chao J., et al. MPD research consortium. Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 105 (2005) 4508-4515
16. Cameron E.E., Bachman K.E., Myöhänen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21 (1999) 103-107
17. Momparler R.L. Pharmacology of 5-Aza-2′-deoxycytidine (decitabine). Semin Hematol 42 (2005) 9-16
18. Dercksen M.W., Gerritsen W.R., Rodenhuis S., et al. Expression of adhesion molecules on CD34+ cells: CD34 + L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 85 (1995) 3313-3319
19. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
20. Christopherson II K.W., Hangoc G., Mantel C.R., and Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305 (2004) 1000-1003
21. Devine S.M., Lazarus H.M., and Emerson S.G. Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplant 31 (2003) 241-252
22. Goff J.P., Shields D.S., and Greenberger J.S. Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34 + Thy+lin- cells. Blood 92 (1998) 4098-4107
23. Cheng T., Rodrigues N., Shen H., et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287 (2000) 1804-1808
24. Stier S., Cheng T., Forkert R., et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 102 (2003) 1260-1266
25. Mahmud N., Katayama N., Itoh R., Tanaka R., Ohishi K., Masuya M., et al. A possible change in doubling time of haemopoietic progenitor cells with stem cell development. Br J Haematol 94 (1996) 242-249
26. Mahmud N., Devine S.M., Weller K.P., et al. The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood 97 (2001) 3061-3068
27. Ho A.D. Kinetics and symmetry of divisions of hematopoietic stem cells. Exp Hematol 33 (2005) 1-8
28. + cells. Blood 96 (2000) 1609-1612
29. + subset following cell division ex vivo. Exp Hematol 27 (1999) 994-1003
30. Zandstra P.W., Conneally E., Petzer A.L., Piret J.M., and Eaves C.J. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A 94 (1997) 4698-4703
31. Prosper F., Stroncek D., McCarthy J.B., and Verfaillie C.M. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of α4β1 integrin expression and function. J Clin Invest 101 (1998) 2456-2467
32. Foguenne J., Di Stefano I., Giet O., Beguin Y., and Gothot A. Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha 4 integrin and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica 94 (2009) 185-194